Abbonarsi

Presenting symptoms of myocardial infarction predict short- and long-term mortality: The MONICA/KORA Myocardial Infarction Registry - 28/11/12

Doi : 10.1016/j.ahj.2012.06.026 
Inge Kirchberger, PhD, MPH a, b, , Margit Heier, MD a, b, Bernhard Kuch, MD c, d, Wolfgang von Scheidt, MD d, Christa Meisinger, MD, MPH a, b
a Central Hospital of Augsburg, MONICA/KORA Myocardial Infarction Registry, Augsburg, Germany 
b Institute of Epidemiology II, German Research Center for Environmental Health (GmbH), Helmholtz Zentrum München, Neuherberg, Germany 
c Department of Internal Medicine/Cardiology, Hospital of Nördlingen, Nördlingen, Germany 
d Department of Internal Medicine I–Cardiology, Central Hospital of Augsburg, Augsburg, Germany 

Reprint requests: Inge Kirchberger, PhD, MPH, MONICA/KORA Myocardial Infarction Registry, Central Hospital of Augsburg, Stenglinstr 2, 86156 Augsburg, Germany.

Riassunto

Background

It is unknown whether clinical outcomes differ with specific symptoms of an acute myocardial infarction (AMI). The objective of this study was to investigate the association between 13 self-reported symptoms and 28-day case fatality or long-term all-cause mortality in patients with AMI.

Methods

The sample consisted of 1,231 men and 415 women aged 25 to 74 years hospitalized with a first-time AMI recruited from a population-based AMI registry. Multivariable logistic regression modeling was used to assess the relationship between symptom occurrence and 28-day case fatality. Cox proportional hazards models were used to determine the effects on long-term mortality. Analyses were adjusted for sex, age, type of AMI, diabetes, prehospital delay time, and reperfusion therapy.

Results

The median observation time was 4.1 years (interquartile range 15 years). Twenty-eight-day case fatality was 6.1%, and long-term mortality was 10.6%. Patients who experienced fear of death (odds ratio [OR] 0.11, 95% confidence interval [CI] 0.03-0.47), diaphoresis (OR 0.45, 95% CI 0.25-0.82), or nausea (OR 0.45, 95% CI 0.22-0.95) had a significantly decreased risk of dying within 28 days, whereas syncope (OR 5.36, 95% CI 2.65-10.85) was associated with a higher risk. A decreased risk for long-term mortality was found for people with pain in the upper abdomen (hazard ratio 0.43, 95% CI 0.19-0.97), whereas dyspnea was related to an increased risk (hazard ratio 1.50, 95% CI 1.11-2.06). The absence of chest symptoms was associated with a 1.85-fold risk for long-term mortality (95% CI 1.13-3.03).

Conclusions

Specific symptoms are associated with mortality. Further research is required to illuminate the reasons for this finding.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2012  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 164 - N° 6

P. 856-861 - Dicembre 2012 Ritorno al numero
Articolo precedente Articolo precedente
  • Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
  • Jennifer B. Christian, John K. Finkle, Bonnie Ky, Pamela S. Douglas, David E. Gutstein, Paul D. Hockings, Pierre Lainee, Daniel J. Lenihan, Jay W. Mason, Philip T. Sager, Thomas G. Todaro, Karen A. Hicks, Robert C. Kane, Hon-Sum Ko, JoAnn Lindenfeld, Eric L. Michelson, James Milligan, Jiefen Y. Munley, Joel S. Raichlen, Amir Shahlaee, Colette Strnadova, Brenda Ye, J. Rick Turner
| Articolo seguente Articolo seguente
  • Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: An analysis from Diuretic Optimization Strategies in Acute Heart Failure
  • Ravi V. Shah, Steven McNulty, Christopher M. O'Connor, G. Michael Felker, Eugene Braunwald, Michael M. Givertz

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.